Kangtai Bio
Kangtai Bio, officially known as Jiangsu Kangtai Biological Products Co., Ltd., is a prominent player in the biopharmaceutical industry, headquartered in China. Founded in 2001, the company has established itself as a leader in the development and production of vaccines and biological products, catering to both domestic and international markets. With a strong focus on innovation, Kangtai Bio offers a diverse range of core products, including inactivated vaccines and recombinant proteins, which are distinguished by their high efficacy and safety profiles. The company has achieved significant milestones, including various certifications and partnerships that enhance its market position. Kangtai Bio's commitment to quality and research has earned it recognition within the industry, making it a trusted name in the biopharmaceutical sector. Its operational reach extends across major regions in Asia, further solidifying its influence in the global market.
DitchCarbon Score
How does Kangtai Bio's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Chemicals industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Kangtai Bio's score of 2 is higher than 64% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Kangtai Bio's reported carbon emissions
In 2023, Kangtai Bio reported total carbon emissions of approximately 105,118,000 kg CO2e, comprising about 15,952,000 kg CO2e from Scope 1 and about 89,165,000 kg CO2e from Scope 2 emissions. This marks an increase in emissions compared to previous years, with 2022 emissions recorded at about 91,015,000 kg CO2e, which included approximately 6,766,000 kg CO2e from Scope 1 and about 84,249,000 kg CO2e from Scope 2. Over the years, Kangtai Bio has shown a trend of increasing emissions, with 2021 emissions at about 73,659,000 kg CO2e, 2020 at approximately 50,398,000 kg CO2e, and 2019 at about 46,839,000 kg CO2e. The company has not disclosed any specific reduction targets or initiatives as part of its climate commitments, indicating a potential area for improvement in its sustainability strategy. Kangtai Bio's emissions data reflects its operational impact on climate change, and the absence of defined reduction targets suggests a need for enhanced climate action and accountability in line with industry standards.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
Add to project| 2019 | 2020 | 2021 | 2022 | 2023 | |
|---|---|---|---|---|---|
| Scope 1 | 2,720,000 | 0,000,000 | 0,000,000 | 0,000,000 | 00,000,000 |
| Scope 2 | 44,118,000 | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 |
| Scope 3 | - | - | - | - | - |
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Kangtai Bio is not committed to any reduction initiatives we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
